|
|
Katherine Sauer |
|
''A model of parallel imports of pharmaceuticals with endogenous price controls'' |
( 2008, Vol. 6 No.36 ) |
|
|
A model is developed to explore the behavior of an original manufacturer with a patent in response to a policy that permits parallel import competition from a country with price controls on the patented good. The model suggests that a manufacturer will limit its supply to the PI-exporting market. The home price is lower only under certain conditions. The relative size of the home market to the potential volume of PIs is a key determinant of the manufacturer's decision to accommodate competition or deter it. Whether the firm accommodates or deters competition, profits fall. |
|
|
Keywords: |
JEL: F1 - Trade: General I1 - Health: General |
|
Manuscript Received : Aug 26 2008 | | Manuscript Accepted : Sep 09 2008 |
|